4F MEDICALS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
4F MEDICALS
Largest movements
- Tangible fixed assets -€8,216
down €8,216 (-3.4%), from €239,256 to €231,040
of which Land and buildings: -€7,724
- Debts after one year -€13,677
down €13,677 (-6.0%), from €226,924 to €213,246
of which Financial debts: -€13,677
- Other debts +€4,494
up €4,494 (+24.1%), from €18,677 to €23,171
- Gross operating margin +€21,705
up €21,705, from -€2,221 to €19,485
- Depreciation -€4,322
down €4,322 (-33.2%), from €13,002 to €8,680
- Financial charges -€480
down €480 (-4.7%), from €10,130 to €9,650
- Other operating charges -€437
down €437 (-22.4%), from €1,951 to €1,515
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €242,619 | €234,801 | -€7,818 | -3.2% |
| Formation expenses | 20 | €1,815 | €1,352 | -€463 | -25.5% |
| Fixed assets | 21/28 | €239,256 | €231,040 | -€8,216 | -3.4% |
| Tangible fixed assets | 22/27 | €239,256 | €231,040 | -€8,216 | -3.4% |
| Land and buildings | 22 | €237,064 | €229,339 | -€7,724 | -3.3% |
| Plant, machinery and equipment | 23 | €452 | €347 | -€105 | -23.2% |
| Furniture and vehicles | 24 | €1,741 | €1,354 | -€387 | -22.3% |
| Current assets | 29/58 | €1,547 | €2,409 | +€862 | +55.7% |
| Cash at bank and in hand | 54/58 | €958 | €1,295 | +€338 | +35.2% |
| Deferred charges and accrued income | 490/1 | €589 | €1,113 | +€524 | +89.0% |
| Total equity and liabilities | 10/49 | €242,619 | €234,801 | -€7,818 | -3.2% |
| Equity | 10/15 | -€17,304 | -€17,664 | -€360 | -2.1% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€27,304 | -€27,664 | -€360 | -1.3% |
| Amounts payable | 17/49 | €259,922 | €252,465 | -€7,458 | -2.9% |
| Amounts payable after more than one year | 17 | €226,924 | €213,246 | -€13,677 | -6.0% |
| Financial debts | 170/4 | €226,844 | €213,166 | -€13,677 | -6.0% |
| Other amounts payable | 178/9 | €80 | €80 | = | 0.0% |
| Amounts payable within one year | 42/48 | €32,221 | €37,364 | +€5,143 | +16.0% |
| Current portion of amounts payable after more than one year | 42 | €13,156 | €13,677 | +€521 | +4.0% |
| Trade debts | 44 | €387 | €515 | +€128 | +33.0% |
| Suppliers | 440/4 | €387 | €515 | +€128 | +33.0% |
| Other amounts payable | 47/48 | €18,677 | €23,171 | +€4,494 | +24.1% |
| Accrued charges and deferred income | 492/3 | €778 | €1,855 | +€1,077 | +138% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €13,002 | €8,680 | -€4,322 | -33.2% |
| Other operating charges | 640/8 | €1,951 | €1,515 | -€437 | -22.4% |
| Gross operating margin | 9900 | -€2,221 | €19,485 | +€21,705 | |
| Operating profit (loss) | 9901 | -€17,174 | €9,290 | +€26,464 | |
| Financial charges | 65/66B | €10,130 | €9,650 | -€480 | -4.7% |
| Recurring financial charges | 65 | €10,130 | €9,650 | -€480 | -4.7% |
| Profit (loss) for the period before taxes | 9903 | -€27,304 | -€360 | +€26,944 | +98.7% |
| Profit (loss) for the period | 9904 | -€27,304 | -€360 | +€26,944 | +98.7% |
| Profit (loss) for the period to be appropriated | 9905 | -€27,304 | -€360 | +€26,944 | +98.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.